Gilead Sciences: all 734 studies

Page 5 of 8. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.

• Rollover Protocol Continued Access to Emtricitabine/Tenofovir Disoproxil Fumarate for Adults in United StatesCompletedNCT00936715Phase 2Results posted
• Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive AdultsCompletedNCT00892437Phase 2Results posted
• ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary FibrosisTerminatedNCT00879229Phase 3Results posted
• Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsCompletedNCT00869557Phase 2Results posted
• Study of Ranexa in Patients With Coronary Artery Disease and Painful PolyneuropathyTerminatedNCT00832572Phase 4Results posted
• Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With BronchiectasisCompletedNCT00805025Phase 2Results posted
• Study of Ambrisentan in Participants With Pulmonary HypertensionCompletedNCT00777920Phase 3Results posted
• (ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPFTerminatedNCT00768300Phase 3Results posted
• Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas AeruginosaCompletedNCT00757237Phase 3Results posted
• Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to EmtricitabineCompletedNCT00743340Phase 2Results posted
• Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to LamivudineCompletedNCT00737568Phase 3Results posted
• A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B InfectionCompletedNCT00736190Phase 4Results posted
• Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B InfectionCompletedNCT00734162Phase 3Results posted
• Safety and Efficacy Study of Switching From Epzicom to TruvadaCompletedNCT00724711Phase 4Results posted
• Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. AeruginosaCompletedNCT00712166Phase 3Results posted
• Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus RaltegravirCompletedNCT00708162Phase 3Results posted
• An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)CompletedNCT00644332Phase 4Results posted
• Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)CompletedNCT00617305Phase 4Results posted
• A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)CompletedNCT00578786Phase 3Results posted
• Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected ChildrenCompletedNCT00528957Phase 3Results posted
• Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver TransplantCompletedNCT00507689Phase 2Results posted
• A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)CompletedNCT00507507Phase 2Results posted
• Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 InfectionCompletedNCT00445146Phase 2Results posted
• Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial HypertensionCompletedNCT00424021Phase 2Results posted
• Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial HypertensionCompletedNCT00423592Phase 2Results posted
• Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary HypertensionCompletedNCT00380068Phase 3Results posted
• Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral TherapyCompletedNCT00352053Phase 3Results posted
• Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to TruvadaCompletedNCT00324649Phase 4Results posted
• TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily TruvadaCompletedNCT00323492Phase 4Results posted
• Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir DipivoxilCompletedNCT00307489Phase 2Results posted
• Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.CompletedNCT00298363Phase 2Results posted
• Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)CompletedNCT00128492Phase 3Results posted
• A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis BCompletedNCT00117676Phase 3Results posted
• A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis BCompletedNCT00116805Phase 3Results posted
• International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. AeruginosaCompletedNCT00112359Phase 3Results posted
• Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected SubjectsCompletedNCT00112047Phase 3Results posted
• Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. AeruginosaCompletedNCT00104520Phase 3Results posted
• Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis BCompletedNCT00095121Phase 3Results posted
• Study of GS-1219 in Participants With HIV-1TerminatedNCT07115368Phase 1
• Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIVActive, not recruitingNCT07055451Phase 1
• Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)Active, not recruitingNCT07047716Phase 3
• Study of GS-3242 in Participants With HIV-1; Substudy-05CompletedNCT07001319Phase 1
• Study of GS-0151 in Participants With Rheumatoid ArthritisActive, not recruitingNCT06902519Phase 1
• Expanded Access for BulevirtideApproved for marketingNCT06780579
• Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01Active, not recruitingNCT06727565Phase 2
• A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in SpainCompletedNCT06683482
• Study of Obeldesivir as Postexposure Prophylaxis for Filovirus Diseases Virus DiseaseWithdrawnNCT06682234Phase 2
• Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1Active, not recruitingNCT06630299Phase 3
• Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1Active, not recruitingNCT06630286Phase 3
• Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been TreatedTerminatedNCT06613685Phase 2/3
• Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically SuppressedActive, not recruitingNCT06544733Phase 2/3
• A Study to Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-cell Cancers That Came Back After Previous TreatmentActive, not recruitingNCT06539338Phase 1
• Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1Active, not recruitingNCT06532656Phase 2/3
• Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)Active, not recruitingNCT06513312Phase 2
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)Active, not recruitingNCT06486441Phase 3
• A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple MyelomaActive, not recruitingNCT06413498Phase 3
• Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With BiktarvyActive, not recruitingNCT06333808Phase 3
• Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06290934Phase 2
• Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaActive, not recruitingNCT06253663Phase 2
• Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)Active, not recruitingNCT06101342Phase 2
• Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)Active, not recruitingNCT06101329Phase 2
• Study of GS-9911 With or Without Antibody Treatment for Adults With Solid TumorsActive, not recruitingNCT06082960Phase 1
• Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell LymphomaActive, not recruitingNCT06079164Phase 1
• Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)CompletedNCT06060665Phase 3
• Study of GS-0272 in Participants With Rheumatoid ArthritisTerminatedNCT06031415Phase 1
• Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06029972Phase 2
• Study of GS-4528 in Adults With Solid TumorsActive, not recruitingNCT05840224Phase 1
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine TherapyActive, not recruitingNCT05840211Phase 3
• Study of Bulevirtide in Participants With Chronic Hepatitis D InfectionTerminatedNCT05718700
• Study With Various Immunotherapy Treatments in Participants With Lung CancerActive, not recruitingNCT05676931Phase 2
• Study of Novel Treatment Combinations in Patients With Lung CancerActive, not recruitingNCT05633667Phase 2
• Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)TerminatedNCT05629208Phase 2
• US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid LeukemiaNo longer availableNCT05627466
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell LymphomaActive, not recruitingNCT05605899Phase 3
• Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung CancerActive, not recruitingNCT05502237Phase 3
• Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell LymphomaCompletedNCT05459571Phase 2
• Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome.Active, not recruitingNCT05457010Phase 1
• Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)Active, not recruitingNCT05396885Phase 2
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast CancerActive, not recruitingNCT05382299Phase 3
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast CancerActive, not recruitingNCT05382286Phase 3
• Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular LymphomaActive, not recruitingNCT05371093Phase 3
• Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)Active, not recruitingNCT05186974Phase 2
• Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) TreatmentWithdrawnNCT05165771Phase 2
• Study of Sacituzumab Govitecan in Patients With Solid TumorActive, not recruitingNCT05119907Phase 2
• Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid TumorsActive, not recruitingNCT05101096Phase 1/2
• Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid TumorsActive, not recruitingNCT05007782Phase 1
• Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid MalignanciesTerminatedNCT05006794Phase 1
• Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Resistant Chronic Spontaneous UrticariaWithdrawnNCT04827589Phase 2
• Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)Active, not recruitingNCT04639986Phase 3
• Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin LymphomaTerminatedNCT04502706Phase 1
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug TherapyWithdrawnNCT04483700Phase 3
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug TherapyWithdrawnNCT04483687Phase 3
• Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406CompletedNCT04467684Phase 1
• Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior TreatmentsActive, not recruitingNCT04454437Phase 2
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)Approved for marketingNCT04323761
• Expanded Access for IMMU-132Approved for marketingNCT04320693
• Study of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell MalignanciesApproved for marketingNCT04162756
• Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple MyelomaActive, not recruitingNCT04155749Phase 1
• A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced CancersTerminatedNCT04025216Phase 1
• Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF)CompletedNCT04009057

← Gilead Sciences overview and focus areas